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Photograph courtesy of Cedars-Sinai Medical Center.David L. Rimoin, M.D., Ph.D. (Figure 1) died on May 27,
2012, only two weeks after being diagnosed with pancre-
atic cancer. David was a towering figure in medical
genetics, a field that he played a pivotal role in creating.
His contributions to the profession in its organization,
education, research, and clinical care have left a permanent
imprint that will always be remembered. The enormous
influence that David had on the careers of others,
including students, his fellows, and colleagues throughout
the world is unparalleled. His departure has left a void that
will be impossible to fill.
David was born in Montreal to middle-class Jewish
parents. The oldest of three children, and the first grand-
child, he grew up knowing the love and importance of
family and carried this viewpoint with him for his entire
life. Education and industriousness were emphasized in
his family, and David stood out as exceptionally bright
from an early age. He once remarked that he could not
remember a time when he did not want to be a medical
doctor, and he pursued this goal at McGill University,
where he obtained his B.Sc., M.Sc., and M.D. degrees. His
two sisters also chose careers in the health professions:
Mona in occupational therapy, and Shirley as a registered
nurse. To be able to afford his education, David lived
at home and worked a variety of jobs from restaurant
dishwasher to carhop, often holding more than one job
at a time.
During his undergraduate and medical training, David
received multiple awards each year, a pattern that would
continue throughout his career. These awards reflected
achievement across a broad range of topics, including
prizes in neurophysiology, microbiology, obstetrics and
gynecology, pathology, clinical medicine, and surgery. He
was introduced to clinical and laboratory genetics by
F. Clarke Fraser and Julius Metrakos, professors of medical
genetics at McGill University. Through this experience he
gained an appreciation for the importance of laboratory
studies but found clinical research more appealing. While
an intern at Royal Victoria Hospital and Montreal Chil-
dren’s Hospital, he completed a master’s degree in genetics
on the topic of the genetics of convulsive disorders.
Because of his interest and early accomplishments in
genetics, he came to the attention of Victor McKusick at
Johns Hopkins University. David told the story of how
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He didn’t believe that it was actually Victor on the phone,
thinking that someone was pulling his leg because ‘‘Victor
McKusick was the most famous person in genetics.’’
However, in 1964, following his residency in internal
medicine, David moved to Johns Hopkins and began a life-
long relationship with both Victor and Anne McKusick.
While there, he also overlapped with many individuals
who would become leaders in the emerging science of
medical genetics and formed many long-lasting personal
and professional friendships.
Concomitant with his fellowship, David earned a Ph.D.
in human genetics at Johns Hopkins, writing his thesis on
genetic disorders of the endocrine glands. The disorders he
studied included growth hormone deficiency, where he
identified the long-suspected autosomal-recessive form of
isolated growth hormone deficiency1 and demonstrated
that growth hormone is not required for either sexual
development or lactation. David also traveled with McKu-
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Figure 2. Clinical Studies of the Pygmies, Central African
Republic, 1965
Photograph from David Rimoin’s archive.communities of Pennsylvania. During this period, David
realized that there were great unexplored clinical differ-
ences among short-statured individuals and that there
might be an opportunity to define these differences both
clinically and genetically. Recognizing a void and filling
it was one of David’s characteristic attributes.
Following the growth hormone studies, David had
the opportunity to join expeditions organized by Luigi L.
Cavalli-Sforza to study pygmies in the Central African
Republic, testing the idea that short stature among the
pygmies was the result of growth hormone deficiency.
Setting up a field clinic for these studies (Figure 2), they
showed that growth hormone was present but that there
was a lack of end-organ responsiveness to its actions.2,3
The phenotype is distinct from the receptor defect under-
lying Laron syndrome, but the underlying cause of short
stature among the pygmies remains unidentified.
David also became interested in the genetics of diabetes
and, although it was clear that the disease was not a simple
Mendelian disorder, in a 1967 paper4 he argued that
diabetes reflects a final common pathway of relative
insulin resistance and/or deficiency and that the under-
lying genetics are heterogeneous, hypothesizing an endo-
crine-type model to explain the potential mechanisms.
His concept of the genetic and etiologic heterogeneity of
diabetes has been amply validated by subsequent studies
worldwide over the past 45 years. He continued to study
the genetics of diabetes and other common diseases,
providing national leadership on these topics. In subse-
quent years, many of these studies were carried out in
Los Angeles in partnership with his longtime colleague
Jerry Rotter.
In 1967 David moved west to assume his first faculty
position and founded the Medical Genetics Clinic at
Washington University in St. Louis, which served and
continues to serve patients there and at St. Louis Children’s
Hospital as well as Barnes-Jewish Hospital. In collaboration404 The American Journal of Human Genetics 91, 403–407, Septembwith Bill Sly, he offered one of the first formal courses
in medical genetics as part of a regular medical school
curriculum. While there, he continued his work on
defining the growth hormone axis in the pygmies and in
endocrine disorders generally. His work in this area led to
publication of a landmark book, Genetic Disorders of the
Endocrine Glands, coauthored with R. Neil Schimke. In
1967, David also received anNIH ResearchCareer Develop-
ment Award to support his research, and he was continu-
ously funded by the NIH from that time onward through
his entire career.
The call of Southern California, with its sunshine, palm
trees, ocean, and opportunity, beckoned him to move
to Los Angeles in 1970. There David again established
a new medical genetics program, this time at Harbor
General Hospital (later renamed Harbor-UCLA Medical
Center), a Los Angeles County hospital providing care to
the indigent. The ability to see patients and carry out
research in a relatively unfettered environment was highly
conducive to allowing David to create a uniquely dynamic
program, which attracted an outstanding cadre of faculty
and fellows (Figure 3). Many of the individuals who got
their start under David’s mentorship would go on to stellar
careers as research investigators, clinicians, department
chairs, and deans.
Also at Harbor, David teamed up with Ralph Lachman to
create the International Skeletal Dysplasia Registry (ISDR),
a referral center for diagnosis, clinical management, and
research on inherited human skeletal dysplasias. The
ISDR became the platform for defining the clinical and
genetic heterogeneity among these disorders, for the
training of many of the current experts in the field, and
for a continuous series of findings that helped reveal the
complexity of skeletal development reflected by patients
with these conditions. Many of the disorders in the
current nosology of the skeletal dysplasias were defined
clinically, genetically, and radiographically by David and
his team, including a long succession of fellows. Subse-
quently, working with Bill Horton, he pioneered the use
of plastic embedding to visualize the growth plate as
a way of distinguishing the different skeletal dysplasias.5
The vast ISDR archive of skeletal tissues and other bio-
logical materials continued to be studied and in recent
years has led to the characterization of the molecular
basis of many of these disorders. This was David’s dream
and long-term goal, and David credited progress in this
endeavor in part to the benefits of being a ‘‘pack rat.’’
The ISDR remains one of the leading centers comprehen-
sively studying the skeletal dysplasias and is one of David’s
lasting legacies.
David published over 400 papers covering the clinical
and molecular basis of skeletal dysplasias, a remarkably
broad spectrum of additional genetic disorders, and policy
papers outlining his views on issues of national impor-
tance in medical genetics. With Alan Emery, he conceived
and edited Principles and Practice of Medical Genetics, a
textbook regarded as the most definitive ander 7, 2012
Figure 3. Medical Genetics Faculty,
Fellows, and Staff at Harbor-UCLA
Medical Center, 1978
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archive.comprehensive reference work in the field. It has served to
educate medical genetics professionals since its initial
publication in 1981, and the sixth edition will be pub-
lished next year.
A part of David’s interest in skeletal disorders stemmed
from his engagement with Little People of America (LPA),
and he and his group participated in local, regional, and
national LPA gatherings to provide clinical care to affected
individuals. He viewed the ISDR and LPA as a way to use his
expertise to give back to the community of individuals
who had contributed so much to his research career. The
LPA honored David’s commitment with an honorary life
membership to the organization.
In 1986 David was recruited as chair of pediatrics to
Cedars-Sinai Medical Center, a UCLA-affiliated commu-
nity hospital, where he occupied the Steven Spielberg
Chair in Pediatrics and started a new program in medical
genetics, the third such program he created. Despite being
an internist by training, David was a force in pediatrics
across the UCLA system (and nationwide), strengthening
the residency program and helping develop the careers of
many young pediatrics faculty members. Eventually he
used his leadership skills to help merge the training
programs at Cedars-Sinai Medical Center and UCLA
Medical Center into a single integrated program. In
medical genetics, Davidwas able to construct a comprehen-
sive program that included everything from prenatal
through adult genetics. Of particular importance was the
creation, with Elizabeth Neufeld, of the UCLA Intercampus
Training Program in Medical Genetics, under which
medical genetics at Cedars-Sinai Medical Center, UCLA
Medical Center, and Harbor-UCLA Medical Center flour-
ished. In his honor, the David L. Rimoin Lectureship was
created to invite a prominent medical geneticist to partic-
ipate in the annual graduation activities of the program.
David stepped down as Chair of Pediatrics in 2004, coinci-The American Journal of Human Gendent with assuming the directorship
of an independent Medical Genetics
Institute.
David provided exemplary leader-
ship at the local, national, and inter-
national levels. His view was that if
he was going to be involved in some-
thing, he might as well run it. How-
ever, he embraced leadership with
equanimity, encouraging the involve-
ment of others and providing them
with opportunity. His confidence in
the abilities of his colleagues, and the
recognition that when good thingshappen there is always enough credit to go around, engen-
dered loyalty that was a hallmark of his professional rela-
tionships. Collaboration on issues of significance,
along with warm, magnetic enthusiasm, made working
with him both successful and a pleasure.
Nowhere was this more evident than in his vision of the
future of medical genetics as a discipline. A subspecialty
typically housed within pediatrics, as early as 19706 David
imagined a time when medical genetics would be an inde-
pendent medical specialty serving the needs of health
professionals and their patients. This future would give
a platform and voice to clinical and laboratory practi-
tioners of medical genetics and genetic counselors as
well as facilitating insurance reimbursement for their
services. It would also bring the benefits of human genetics
research to patients and their families. To this end, he
worked to establish the 12-person founding board of
directors of the American Board of Medical Genetics and
served as its founding president from 1979 to 1983. His
vision was rewarded when, in 1991, medical genetics was
approved as the 24th full medical specialty of the American
Board of Medical Specialties (ABMS), the first new specialty
in 12 years.
A part of this effort was the politically delicate need
to separate the accrediting body for genetic counselors
into its own entity. David had great respect for genetic
counselors, thought that there were too few nationally to
serve the needs of patients, and did not want to disenfran-
chise them from the larger medical genetics community.
At the same time, the benefits of specialty recognition by
the ABMS were too great to be set aside over this issue.
He participated in solving this problem by helping to
create the American Board of Genetic Counseling and
the National Society of Genetic Counselors as two inde-
pendent bodies, distinct from the American College of
Medical Genetics and the American Board of Medicaletics 91, 403–407, September 7, 2012 405
Figure 4. Lauren, David, Annie, Ann, and Michael circa 1992
Photograph courtesy of Ann Garber.Genetics. David then participated in the formation of the
Council of Medical Genetics Organizations (COMGO) as
an umbrella organization for keeping all genetics profes-
sionals and lay organizations integrated and interactive,
and he served as that organization’s founding president.
In retrospect, David felt that all of the medical genetics
stakeholders benefitted from this evolution.
The new specialty of medical genetics needed a voice
separate from the American Society of Human Genetics,
an organization that David was the president of in 1984,
so David helped to organize the American College of
Medical Genetics (ACMG) and became its founding
president, serving from 1992 to 1998. The growth of the
College and the success of its independent mission and
annual meeting were a source of great satisfaction to
David. Subsequently, he served as president of the Amer-
ican College of Medical Genetics Foundation, the
nonprofit fundraising arm of the College. Although the
Foundation raises and provides funding for many worthy
ACMG activities, David was especially interested in using
the ACMG as a primary motivator to attract younger
people to the field. In his honor, the ACMG Foundation
has established the David L. Rimoin Lifetime Achievement
Award. (Contributions in David’s memory to the endow-
ment supporting this award can be made at http://www.
acmgfoundation.org/rimoin.)
In recognition of his accomplishments, David received
many of the most prestigious awards in his field, some of
which are summarized here. Early on he received the
Ross Outstanding Young Investigator Award from the
Western Society for Pediatric Research and the E. Mead
Johnson Award for Research in Pediatrics from the
American Academy of Pediatrics. He was elected to the
Institute of Medicine of the National Academy of Sciences
in 1992 and was a fellow of the American Association
for the Advancement of Science. David was engaged with
the March of Dimes throughout his career and received406 The American Journal of Human Genetics 91, 403–407, Septembthe Colonel Harland Sanders Award for Lifetime Achieve-
ment in the genetic sciences. He was the first recipient
of the McKusick Leadership Award from the American
Society of Human Genetics, an award dear to him because
it was named for his mentor. In recent years he received
lifetime achievement awards from the American College
of Medical Genetics and the Western Society for Clinical
Investigation. Last year he was thrilled to receive the
Distinguished Alumnus Award from Johns Hopkins
University and just this year was named a Master by the
American College of Physicians.
Beyond the effect David had on national policy in
genetics, over 150 fellows trained with him. Many became
leaders in clinical research in genetics, particularly in
skeletal dysplasia research, but David also recognized and
fully supported fellows who wanted to be practicing clin-
ical geneticists. David was proud of each one of them,
regarding them with nearly as much pride as he had in
his own children, and there was a bond among Rimoin
fellows, even those who did not overlap during their
training. He was as encouraging and passionate about
individual trainees as he was regarding initiatives with
national impact. He was especially proud of the many
Israeli fellows who trained with him and their subsequent
impact on genetics in Israel.
David was continuously engaged in promoting the
careers of his former fellows, faculty, and colleagues by
nominating them for awards recognizing their accom-
plishments, supporting accelerated promotions for
deserving individuals, inviting them to committee meet-
ings or conferences to get them involved in activities he
thought might benefit them, and generally advocating
on their behalf. His advocacy also included his mentor,
as David successfully nominated Victor McKusick for the
Lasker Award. He enjoyed when others were acknowledged
as much as he appreciated the awards given to him. On
such occasions, he did not miss the opportunity to cele-
brate, recognizing the joy and importance of such mile-
stone events. His genuine warmth and gentle nature led
to a long list of treasured collegial relationships and friend-
ships.
If one could characterize it as a hobby, David’s was travel.
He never tired of going to far-flung places throughout the
world to participate in conferences and visit with friends
and colleagues. In recent years he enjoyed contributing
to the Human Variome Project, for which he chaired the
Scientific Advisory Committee. He saw his role as advo-
cating for the understanding the clinical consequences of
human DNA sequence variation. He was fond of saying
that ‘‘genotype without phenotype leads to missense or
nonsense.’’ Frequently he would augment his trips with
a vacation, especially on a beach, on those occasions
when he was accompanied by Ann, his wife of 32 years,
who was his best friend and life partner. As much as he
relished his professional work, Ann and his three children,
Annie, Michael, and Lauren, were the center of his life
(Figure 4). Each of his children has achieved professionaler 7, 2012
success, and they attribute a part of that to his positive
encouragement. He took great pride in Annie, a tenured
professor at the UCLA School of Public Health, and her
work studying emerging viruses in Africa. It reminded
him of the pygmy expeditions, and the two of them had
been planning a new project to finally determine the
genetic basis of height in the pygmy population. He was
equally supportive of Michael, an M.B.A. with a passion
for environmental sustainability in the fields of local
food systems and energy, and provided counsel to Lauren
in her desire to follow in his footsteps to become a medical
doctor. Through his tremendous capacity for love of
family, David set an example for living.
When David was diagnosed with pancreatic cancer, he
didn’t want to tell anyone, in part because he didn’t
want to detract from Lauren’s UCLA Medical School grad-
uation, at which he was planning to participate in her
hooding ceremony. However, the disease progressed too
rapidly to allow this. Consequently, with permission
from the dean of the David Geffen School of Medicine, Eu-
gene Washington, Lauren’s graduation ceremony was held
at David’s hospital bedside in the presence of family and
close friends. It was a joyous occasion with balloons,
photographs, tears, and smiles. With great pride, David
placed the hood on Lauren. He showed great dignity, poise,
and strength.
David did have a chance to reflect on his life and was
very content with all that he had achieved, which he
said was far more than he could have ever hoped to accom-
plish. He felt grateful and fulfilled and believed that he hadThe Americanmade a positive difference in both his professional and
personal life. He stated that his reward was the ability to
do what he loved for his entire life. His was a life of signif-
icance, kindness, and collaboration, with a legacy repre-
sented by the individuals he touched and an indelible
imprint on the world that will be remembered always.
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